Article

Addition Technology acquires CooperVision Surgical products

Des Plaines, IL-Addition Technology Inc., maker of Intacs corneal implants for keratoconus and myopia, has acquired AlphaCor and AlphaSphere from CooperVision Surgical.

Des Plaines, IL-Addition Technology Inc., maker of Intacs corneal implants for keratoconus and myopia, has acquired AlphaCor and AlphaSphere from CooperVision Surgical.

AlphaCor is a flexible, biodegradable, one-piece artificial cornea (keratoprosthesis) designed to replace scarred or diseased native cornea. It is designed for use in patients in whom cornea transplants have failed multiple times or in those patients for whom a donor graft is likely to fail.

AlphaSphere is a soft, biocompatible orbital implant that the company plans to launch later this year. It has received FDA approval for the treatment of patients who have lost an eye due to disease or trauma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.